Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

The evolving role of FLT3 inhibitors in acute myeloid leukemia: quizartinib and beyond.

The evolving role of FLT3 inhibitors in acute myeloid leukemia: quizartinib and beyond. Ther Adv Hematol. 2014 Jun; 5(3):65-77.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.